Navigation Links
InterMune Announces Proposed Public Offering of Common Stock
Date:11/4/2013

nificant risks and uncertainties, actual results could differ materially from those projected and InterMune cautions investors not to place undue reliance on the forward-looking statements contained in this release.  These risks and uncertainties include, without limitation, risks and uncertainties related to market conditions and satisfaction of customary closing conditions related to the public offering.  There can be no assurance that InterMune will be able to complete the public offering on the anticipated terms, or at all.  If InterMune is unable to raise additional capital when required or on acceptable terms, it may have to significantly delay, scale back or discontinue one or more of its drug development or discovery research programs.  Additional risks and uncertainties relating to InterMune and its business can be found in the "Risk Factors" section of InterMune's annual report on Form 10-K and quarterly reports on Form 10-Q filed with the SEC, and in the prospectus supplement related to the proposed offering to be filed with the SEC.  InterMune undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in InterMune's expectations.


'/>"/>
SOURCE InterMune, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. InterMune to Divest Actimmune® (Interferon Gamma-1b)
2. InterMune Reports Second Quarter 2012 Financial Results and Business Highlights
3. InterMune Announces Presentations of New Research in IPF at ERS
4. Sean P. Nolan Joins InterMune as Executive Vice President and Chief Business Officer
5. InterMune Reports Second Quarter 2013 Financial Results And Business Highlights
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , Mar. 02, 2015 Research and Markets ... addition of the "Lopinavir - Comprehensive patent ... Imagine having your own team of ... button. Used by the world,s leading ... years, these searches are the benchmark in comprehensive, ...
(Date:3/2/2015)... Shire plc (LSE: SHP, NASDAQ: SHPG ... Drug Application (NDA) with the U. S. Food and Drug ... signs and symptoms of dry eye disease in adults. ... to address both the signs and symptoms of dry eye ... said Philip J. Vickers , Ph.D., Head of Research ...
(Date:3/2/2015)... , March 2, 2015 The Economist ... London last week on 26 February was host to ... on a number of topical issues facing the sector. This year,s ...   E ra , , observed the challenges the ... them. Panel speakers offered contrasting and thought-provoking commentary on ...
Breaking Medicine Technology:Global Comprehensive Lopinavir Patent Search Online Portal 2015 2Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults 2Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults 3Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults 421 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 221 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 321 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 421 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 521 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 6
(Date:3/2/2015)... March 02, 2015 Doctors in Novara, ... a better predictor of outcomes for people with mesothelioma ... details of the new study on the Surviving ... the University of Eastern Piedmont followed the cases of ... treatment for excess lung fluid. , “Persistent lung ...
(Date:3/2/2015)... 02, 2015 Burns Engineering's Lab-to-Lab ... for Secondary Standard Platinum Resistance Thermometers (SSPRTs) and ... days or less . . . guaranteed. ... Accredited (Lab Code 200706-0), ISO 9001 and 17025 ... range is -196°C to 500°C, both ITS-90 and ...
(Date:3/2/2015)... The minimally invasive surgical instruments market is expected ... reach $14,133.0 million by 2019 from $10,526.2 million ... of minimally invasive surgeries over traditional open surgeries, ... and increasing number of surgical procedures among the ... surgical instruments market. , For More Details @ ...
(Date:3/2/2015)... Four Seasons Resort Maui at Wailea, the ... this year, having officially opened its doors on March 2, ... honoring over 70 employees who started on Day 1 and ... approximately 400 original employees. The celebration will be a ... , This Four Seasons flagship resort, the first resort ...
(Date:3/2/2015)... Bangladesh (PRWEB) March 02, 2015 The ... of fire safety expert Mark Chubb to serve as ... fire safety operations and training in Bangladesh and guide ... source. , “Mark will ensure that the Alliance ... fire safety programs for Bangladesh garment workers,” said Alliance ...
Breaking Medicine News(10 mins):Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2
... flu antibodies in migrant birds in five Siberian regions, a ... ,"Out of over 4,000 samples taken in the area ... contain genetic material of the A-H5 virus and antibodies in ... said the presence of antibodies meant that either the birds ...
... two studies indicate that elevated nonfasting triglyceride levels ... heart attack , with one study finding that ... this association. ,Triglyceride levels are usually ... certain types of lipoprotein particles (remnant lipoproteins), a ...
... they have been discharged from hospital for an asthma attack ... Review has found. Giving the steroids also reduces their use ... ,This updated finding was drawn after reviewing data in ... and 16% of people who are discharged from hospital after ...
... and exercise is a more effective way of losing weight ... gain weight during pregnancy and many gradually lose it afterwards, ... weight. This retained body weight may be one factor that ... find ways of returning to, and maintaining, pre-pregnant weights, and ...
... Cochrane Systematic Review has concluded,Spraying salty water (saline) into ... and congestion that accompany long-term infections of the ... people experience persistent infection of the nasal passages (chronic ... spraying saline into the nose to relieve symptoms, and ...
... heart beats and have a tendency to form blood clots ... clots can then travel to the brain, block vessels and ... risk of this occurring is to give drugs that limit ... are anticoagulants that inhibit the clotting process (e.g. warfarin), and ...
Cached Medicine News:Health News:High Nonfasting Triglyceride Levels Linked With Cardiovascular Risks 2Health News:Anticoagulants is Better for Atrial Fibrillation 2
... Ophthalmic Products provide the ... free products for unparalleled ... cleaning of fine microsurgical ... material is highly absorbent, ...
... Merocel Ophthalmic Products provide ... fiber free products for ... safe cleaning of fine ... Merocel material is highly ...
... Products provide the surgeon ... products for unparalleled fluid ... of fine microsurgical instruments. ... is highly absorbent, fast ...
Hard protective shields for post-operative or post-injury use. Universal, or Left/Right specific. Packaged 12 per box....
Medicine Products: